Notable paradoxical phenomena in associations between cardiovascular health score, subclinical and clinical cardiovascular disease in the community: The Framingham Heart Study.
Journal
PloS one
ISSN: 1932-6203
Titre abrégé: PLoS One
Pays: United States
ID NLM: 101285081
Informations de publication
Date de publication:
2022
2022
Historique:
received:
13
01
2022
accepted:
05
04
2022
entrez:
5
5
2022
pubmed:
6
5
2022
medline:
10
5
2022
Statut:
epublish
Résumé
Cardiovascular Health (CVH) scores are inversely associated with prevalent subclinical (SubDz) and incident cardiovascular disease (CVD). However, the majority of people who develop CVD have intermediate or ideal CVH scores, while many with poor CVH profiles escape CVD development. To describe the prevalence of paradoxical relations among CVH, SubDz, and CVD. Cohort study, Framingham Study data collected prospectively (1995-2016). Population-based. 7,627 participants (mean age 49 years, 53% women) attending Offspring examinations 6/7 and Third Generation examinations 1/2. CVH score (range 0-14) constructed from poor, intermediate, or ideal status for each metric (smoking, diet, physical activity, blood pressure, body mass index, fasting glucose, total cholesterol); and prevalent SubDz (≥1 of: increased carotid intimal media thickness, CIMT; left ventricular hypertrophy, LVH; microalbuminuria, MA; elevated ankle brachial index, ABI; coronary artery calcium score ≥100,CAC). Ideal CVH (scores 12-14), intermediate CVH (scores 8-11), and poor CVH (0-7). We described three distinct paradoxical phenomena, involving combinations of CVH, SubDz, and CVD, and generated CVD incidence rates and predicted CVD probabilities for all combinations. We observed 842 CVD events (median follow-up 13.7 years); 1,663 participants had SubDz. Most individuals with poor CVH (78%) or SubDz (57% for CIMT to 77% for LVH) did not develop CVD on follow-up. Among participants with incident CVD, the majority had intermediate or ideal CVH (68%) or absent SubDz (46% for CAC to 96% for ABI) at baseline. We observed similar paradoxical results in relations between CVH and prevalent SubDz. Poor CVH and prevalent SubDz were each associated with higher CVD incidence rates compared to intermediate or ideal CVH and absent SubDz, respectively. The predicted CVD probability was nearly three-times greater among participants with poor (22%) versus intermediate or ideal CVH (8%). Mean CVD predicted probabilities were nearly three (26% vs. 10% for MA) to six-times (29% vs. 5% for CAC) greater among participants with SubDz versus without SubDz. Findings were consistent within age and sex strata. Although poor CVH and SubDz presence are associated with CVD incidence, paradoxical phenomena involving CVH, SubDz, and CVD are frequently prevalent in the community. Further studies to elucidate biological mechanisms underlying these phenomena are warranted.
Identifiants
pubmed: 35511823
doi: 10.1371/journal.pone.0267267
pii: PONE-D-22-01215
pmc: PMC9070900
doi:
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Research Support, N.I.H., Extramural
Langues
eng
Sous-ensembles de citation
IM
Pagination
e0267267Subventions
Organisme : NHLBI NIH HHS
ID : N01HC25195
Pays : United States
Organisme : NHLBI NIH HHS
ID : HHSN268201500001I
Pays : United States
Organisme : NHLBI NIH HHS
ID : 75N92019D00031
Pays : United States
Déclaration de conflit d'intérêts
The authors have declared that no competing interests exist.
Références
Am J Epidemiol. 1979 Sep;110(3):281-90
pubmed: 474565
JACC Heart Fail. 2013 Feb;1(1):79-83
pubmed: 23998002
J Am Heart Assoc. 2017 Mar 20;6(3):
pubmed: 28320747
Am J Prev Med. 2016 Oct;51(4):502-6
pubmed: 27539974
Circulation. 2014 Nov 4;130(19):1676-83
pubmed: 25274000
Clin Cardiol. 2017 Dec;40(12):1339-1346
pubmed: 29278429
N Engl J Med. 1999 Jan 7;340(1):14-22
pubmed: 9878640
Circulation. 2010 Feb 2;121(4):586-613
pubmed: 20089546
Diabetes. 2007 Jun;56(6):1718-26
pubmed: 17369522
Arch Intern Med. 2003 Sep 8;163(16):1939-42
pubmed: 12963567
Eur Heart J. 2017 Jun 14;38(23):1815-1822
pubmed: 28379333
J Am Coll Cardiol. 2015 Oct 6;66(14):1633-1634
pubmed: 26429090
Int J Cardiol. 2015 Apr 15;185:186-91
pubmed: 25797675
Am J Cardiol. 2008 Nov 1;102(9):1136-41, 1141.e1
pubmed: 18940279
Circ Cardiovasc Imaging. 2018 Jan;11(1):e006209
pubmed: 29305347
Stroke. 2016 May;47(5):1201-6
pubmed: 27073239
BMC Med Genet. 2007 Sep 19;8 Suppl 1:S17
pubmed: 17903299
JAMA Cardiol. 2020 May 1;5(5):549-556
pubmed: 32159731
Am J Med. 2019 Oct;132(10):1182-1190.e5
pubmed: 31278932
Mayo Clin Proc. 2016 May;91(5):649-70
pubmed: 27040086
Circ Cardiovasc Imaging. 2017 Oct;10(10):
pubmed: 28956774
Lancet. 2001 Nov 17;358(9294):1682-6
pubmed: 11728544
Eur Heart J. 2004 Mar;25(6):523-30
pubmed: 15039133
Arch Intern Med. 2006 Jan 9;166(1):71-8
pubmed: 16401813
Br Med J (Clin Res Ed). 1981 Jun 6;282(6279):1847-51
pubmed: 6786649
JAMA. 2000 Jan 12;283(2):221-8
pubmed: 10634338
J Am Coll Cardiol. 2019 Jun 25;73(24):e285-e350
pubmed: 30423393
J Am Heart Assoc. 2014 Mar 10;3(2):e000532
pubmed: 24614756
Circulation. 2007 Jul 24;116(4):375-84
pubmed: 17620505
Arterioscler Thromb Vasc Biol. 2016 Oct;36(10):2115-24
pubmed: 27585698
Am J Epidemiol. 2007 Jun 1;165(11):1328-35
pubmed: 17372189
J Am Heart Assoc. 2018 May 17;7(11):
pubmed: 29773573
Circulation. 2015 Nov 24;132(21):1979-89
pubmed: 26350059
J Am Soc Echocardiogr. 2015 Jan;28(1):1-39.e14
pubmed: 25559473
Circ Heart Fail. 2016 Jan;9(1):e002416
pubmed: 26699391
JAMA. 2012 Mar 28;307(12):1273-83
pubmed: 22427615
Circulation. 2021 Feb 23;143(8):e254-e743
pubmed: 33501848
Am J Hypertens. 2004 Oct;17(10):986-93
pubmed: 15485765
Ann Epidemiol. 2012 May;22(5):303-9
pubmed: 22424967
N Engl J Med. 2011 Jul 21;365(3):213-21
pubmed: 21774709